These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27087351)

  • 1. Pseudotumour Cerebri Presentation in a Child Under the Gonadotropin-Releasing Hormone Agonist Treatment.
    Gül Ü; Kaçar Bayram A; Kendirci M; Hatipoğlu N; Okdemir D; Gümüş H; Kurtoğlu S
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):365-7. PubMed ID: 27087351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension during therapy with triptorelin in a girl with precocious puberty.
    Calcaterra V; Mannarino S; Corana G; Codazzi AC; Mazzola A; Brambilla P; Larizza D
    Indian J Pediatr; 2013 Oct; 80(10):884-5. PubMed ID: 23180401
    [No Abstract]   [Full Text] [Related]  

  • 3. Arterial hypertension during treatment with triptorelin in a child with Williams-Beuren syndrome.
    Siomou E; Kosmeri C; Pavlou M; Vlahos AP; Argyropoulou MI; Siamopoulou A
    Pediatr Nephrol; 2014 Sep; 29(9):1633-6. PubMed ID: 24604705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist.
    Yeshaya A; Kauschansky A; Orvieto R; Varsano I; Nussinovitch M; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):327-9. PubMed ID: 9539281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hair loss in children on long-acting gonadotropin-releasing hormone agonist triptorelin treatment.
    Kauschansky A; Lurie R; Ingber A
    Acta Derm Venereol; 1997 Jul; 77(4):333. PubMed ID: 9228240
    [No Abstract]   [Full Text] [Related]  

  • 6. [True precocious puberty in girl. Therapy with LHRH analogs].
    Wasikowa R; Iwanicka Z; Pellar J; Hirowska I; Barg E
    Kinderarztl Prax; 1990 Jul; 58(7):335-40. PubMed ID: 2145459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty.
    Tung YC; Lee JS; Tsai WY; Hsiao PH
    J Formos Med Assoc; 2007 Oct; 106(10):826-31. PubMed ID: 17964961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of precocious puberty by GnRH agonists].
    Carel JC
    Ann Urol (Paris); 2005 Oct; 39 Suppl 3():S85-8. PubMed ID: 16302717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility of Women Treated during Childhood with Triptorelin (Depot Formulation) for Central Precocious Puberty: The PREFER Study.
    Martinerie L; de Mouzon J; Blumberg J; di Nicola L; Maisonobe P; Carel JC;
    Horm Res Paediatr; 2020; 93(9-10):529-538. PubMed ID: 33774631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptorelin (Triptodur) for central precocious puberty.
    Med Lett Drugs Ther; 2018 Jan; 60(1537):7-8. PubMed ID: 29294465
    [No Abstract]   [Full Text] [Related]  

  • 11. Does the risk of arterial hypertension increase in the course of triptorelin treatment?
    Palma L; Gaudino R; Cavarzere P; Antoniazzi F
    J Pediatr Endocrinol Metab; 2020 Mar; 33(3):449-452. PubMed ID: 30091950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment.
    Antoniazzi F; Bertoldo F; Lauriola S; Sirpresi S; Gasperi E; Zamboni G; Tatò L
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1992-6. PubMed ID: 10372699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
    Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
    Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of stress levels in girls with central precocious puberty before and during long-acting gonadotropin-releasing hormone agonist treatment: a pilot study.
    Menk TAS; Inácio M; Macedo DB; Bessa DS; Latronico AC; Mendonca BB; Brito VN
    J Pediatr Endocrinol Metab; 2017 May; 30(6):657-662. PubMed ID: 28599388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient developing anaphylaxis and sensitivity to two different GnRH analogues and a review of literature.
    Ökdemir D; Hatipoğlu N; Akar HH; Gül Ü; Akın L; Tahan F; Kurtoğlu S
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):923-5. PubMed ID: 25719301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual cycle pattern during the first gynaecological years in girls with precocious puberty following gonadotropin-releasing hormone analogue treatment.
    Arrigo T; De Luca F; Antoniazzi F; Galluzzi F; Iughetti L; Pasquino AM; Salerno MC; Marseglia L; Crisafulli G
    Eur J Pediatr; 2007 Jan; 166(1):73-4. PubMed ID: 16906400
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study.
    Magiakou MA; Manousaki D; Papadaki M; Hadjidakis D; Levidou G; Vakaki M; Papaefstathiou A; Lalioti N; Kanaka-Gantenbein C; Piaditis G; Chrousos GP; Dacou-Voutetakis C
    J Clin Endocrinol Metab; 2010 Jan; 95(1):109-17. PubMed ID: 19897682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine.
    Roth CL; Brendel L; Rückert C; Hartmann K
    Horm Res; 2005; 63(5):257-62. PubMed ID: 15995342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate.
    Zenaty D; Blumberg J; Liyanage N; Jacqz-Aigrain E; Lahlou N; Carel JC;
    Horm Res Paediatr; 2016; 86(3):188-195. PubMed ID: 27603324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.